0.035
0.01 (25.45%)
| Previous Close | 0.028 |
| Open | 0.030 |
| Volume | 128,363 |
| 52 Weeks Range |
| Profit Margin | -16.44% |
| Operating Margin (TTM) | -11.90% |
| Diluted EPS (TTM) | -602.09 |
| Quarterly Revenue Growth (YOY) | 16.90% |
| Total Debt/Equity (MRQ) | 3,434.19% |
| Current Ratio (MRQ) | 2.15 |
| Operating Cash Flow (TTM) | -26.54 M |
| Levered Free Cash Flow (TTM) | -7.46 M |
| Return on Assets (TTM) | -19.67% |
| Return on Equity (TTM) | -213.36% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Bearish |
| Medical Care Facilities (Global) | Mixed | Bearish | |
| Stock | The Oncology Institute Inc | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | NA |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | 0.00 |
|
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Davidson Kempner Capital Management Lp | 31 Dec 2024 | 318,710 |
| Tenor Capital Management Co., L.P. | 31 Dec 2024 | 25,000 |
| Freegulliver Llc | 31 Dec 2024 | 18,500 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |